IMPORTANT NOTICE: At Fortis Healthcare, we are fully supportive of the National priorities set out by the Hon’ble Prime Minister of India. Further to the directives of the Government provided in their press release dated 8th Nov 2016, payments at Government hospitals can be made through 500 and 1000 Rupee denomination notes. In view of the hardship being caused to the large number of patients at private hospitals, we have made an urgent representation to the Government that this exemption should apply equally, for payments, at private hospitals. We are following up with the authorities and hope the Government will step in quickly to resolve this anomaly. Meanwhile, at Fortis hospitals across the country, we continue to accept payments through credit card, debit card and electronic banking transfers. As 500 and 1000 Rupee denomination notes are no longer legal tender we are only accepting 100 Rs and lower currency notes. As per Government regulation, a PAN card and legitimate ID proof is however required for payments in cash exceeding Rs 50,000. Meanwhile we continue to ensure that emergency cases get immediate medical attention without delay whatsoever and have put in more administrative staff and help desks to assist patients.

Doctor Profile

Dr. K.P.Singh

Dr. K.P.Singh, D.M.

24+ Years Of Experience

Additional Director Fortis Hospital, Mohali

Endocrinology

OPD Schedule - +91 172 469 2222, +91 172 502 1222

  • Mon

    09:30 AM - 04:30 PM

  • Tue

    09:30 AM - 04:30 PM

  • Wed

    09:30 AM - 04:30 PM

  • Thu

    09:30 AM - 04:30 PM

  • Fri

    09:30 AM - 04:30 PM

  • Sat

    09:30 AM - 04:30 PM


  • Request Appointment

DM-Endocrinology-1991, FICN

Working as Additional Director, Endocrinology, at Fortis Mohali for the last 13 years. Prior to this, worked as an Assistant Professor Endocrinology in P.G.I.M.E.R Chandigarh for 3 years and established department of Endocrinology at SV Institute of Medical Sciences, Tirupati, Andhra Pradesh. Recipient of the 2007 WHO International Diabetes Center Award from Minneapolis and National Builders Award, 2007. His biography has been included in the 2008 Marquis Who's Who In World. He has 24 years of experience as an Endocrinologist and has published 45 articles in International Journals on Diabetes, Thyroid, Metabolic Bone Disease and Growth Hormone. Few studies like growth hormone therapy in burns, chronic fluoride toxicity in children, Metformin Osteoporosis link are the first land mark studies in the world. These studies have been highlighted in Medline and also received International media response in BBC, USA Today etc. He is a Member and Regular Participant of Annual Conferences of American Diabetic Association (ADA), American Endocrine Society (AES), American Association of Clinical Endocrinologist (AACE) and ASBMR (American Society for Bone Mineral Research). Also an active member of many NGO’s who are working in the health sector. Parathyroid Adenoma was treated first time in Asia and America by non-surgical technique (HIFU).
Designation: Additional Director
Department: Diabetology & Endocrinology Languages spoken: English, Hindi & Punjabi
Total Years’ of Experience: 23 yrs

Previous experience: Prior to joining Fortis Hospital Mohali, Dr. Singh worked as an Assistant Professor Endocrinology in P.G.I.M.E.R Chandigarh for 3 years. He was instrumental in establishing the Department of Endocrinology, S.V. Institute of Medical Sciences Tirupati Andhra Pradesh.

Medical Education, Certifications and fellowships/Research Papers:
MBBS 1985
MD (Medicine) 1988
DM (Endocrinology) 1991
Global Advanced Therapeutics and Technologies in Diabetes Care program 2007
FICN (Fellow International College of Nutrition)

Professional Memberships: He is a Member and Regular Participant of Annual Conferences of American Diabetic Association (ADA), American Endocrine Society (AES), American Association of Clinical Endocrinologist (AACE) and ASBMR (American Society for Bone Mineral Research), Member of EASD and ICE. Also an active member of many NGO’s who are working for the health sector.

Clinical Interests/ Specialised Treatments /Area of Expertise: Growth hormone therapy in burns, chronic fluoride toxicity in children and Metformin Osteoporosis link, HIFU treatment of parathyroid Adenoma (1st time in Asia)
Awards & Honors (If any): Dr Singh is a recipient of WHO International Diabetes Center award from Minneapolis 2007 and National Builders Award 2007. His biography has been included in the 2008 Marquis Who’s Who In World and Oxford International Biographical Centre, Cambridge, UK.
Research and Publications (If any): Total of 45 Publications as original articles and abstracts in international conference proceedings
Medical Breakthroughs/ Interesting Case Studies:
• Growth Hormone Therapy in Burns on Mortality (First time in Asia)
• Treated Parathyroid Adenoma by HIFU (First time in Asia and America)
• Metformin and osteoporosis link
Profile: Working as Additional Director, Endocrinology, at Fortis Mohali for the last 13 years. Prior to this, worked as an Assistant Professor Endocrinology in P.G.I.M.E.R Chandigarh for 3 years and established department of Endocrinology at SV Institute of Medical Sciences, Tirupati, Andhra Pradesh. Recipient of the 2007 WHO International Diabetes Center Award from Minneapolis and National Builders Award, 2007. His biography has been included in the 2008 Marquis Who's Who In World. He has 24 years of experience as an Endocrinologist and has published 45 articles in International Journals on Diabetes, Thyroid, Metabolic Bone Disease and Growth Hormone. Few studies like growth hormone therapy in burns, chronic fluoride toxicity in children, Metformin Osteoporosis link are the first land mark studies in the world. These studies have been highlighted in Medline and also received International media response in BBC, USA Today etc. He is a Member and Regular Participant of Annual Conferences of American Diabetic Association (ADA), American Endocrine Society (AES), American Association of Clinical Endocrinologist (AACE) and ASBMR (American Society for Bone Mineral Research). Also an active member of many NGO’s who are working in the health sector. Parathyroid Adenoma was treated first time in Asia and America by non-surgical technique (HIFU).
Designation: Additional Director
Department: Diabetology & Endocrinology Languages spoken: English, Hindi & Punjabi
Total Years’ of Experience: 23 yrs

Previous experience: Prior to joining Fortis Hospital Mohali, Dr. Singh worked as an Assistant Professor Endocrinology in P.G.I.M.E.R Chandigarh for 3 years. He was instrumental in establishing the Department of Endocrinology, S.V. Institute of Medical Sciences Tirupati Andhra Pradesh.

Medical Education, Certifications and fellowships/Research Papers:
MBBS 1985
MD (Medicine) 1988
DM (Endocrinology) 1991
Global Advanced Therapeutics and Technologies in Diabetes Care program 2007
FICN (Fellow International College of Nutrition)

Professional Memberships: He is a Member and Regular Participant of Annual Conferences of American Diabetic Association (ADA), American Endocrine Society (AES), American Association of Clinical Endocrinologist (AACE) and ASBMR (American Society for Bone Mineral Research), Member of EASD and ICE. Also an active member of many NGO’s who are working for the health sector.

Clinical Interests/ Specialised Treatments /Area of Expertise: Growth hormone therapy in burns, chronic fluoride toxicity in children and Metformin Osteoporosis link, HIFU treatment of parathyroid Adenoma (1st time in Asia)
Awards & Honors (If any): Dr Singh is a recipient of WHO International Diabetes Center award from Minneapolis 2007 and National Builders Award 2007. His biography has been included in the 2008 Marquis Who’s Who In World and Oxford International Biographical Centre, Cambridge, UK.
Research and Publications (If any): Total of 45 Publications as original articles and abstracts in international conference proceedings
Medical Breakthroughs/ Interesting Case Studies:
• Growth Hormone Therapy in Burns on Mortality (First time in Asia)
• Treated Parathyroid Adenoma by HIFU (First time in Asia and America)
• Metformin and osteoporosis link
Profile: Working as Additional Director, Endocrinology, at Fortis Mohali for the last 13 years. Prior to this, worked as an Assistant Professor Endocrinology in P.G.I.M.E.R Chandigarh for 3 years and established department of Endocrinology at SV Institute of Medical Sciences, Tirupati, Andhra Pradesh. Recipient of the 2007 WHO International Diabetes Center Award from Minneapolis and National Builders Award, 2007. His biography has been included in the 2008 Marquis Who's Who In World. He has 24 years of experience as an Endocrinologist and has published 45 articles in International Journals on Diabetes, Thyroid, Metabolic Bone Disease and Growth Hormone. Few studies like growth hormone therapy in burns, chronic fluoride toxicity in children, Metformin Osteoporosis link are the first land mark studies in the world. These studies have been highlighted in Medline and also received International media response in BBC, USA Today etc. He is a Member and Regular Participant of Annual Conferences of American Diabetic Association (ADA), American Endocrine Society (AES), American Association of Clinical Endocrinologist (AACE) and ASBMR (American Society for Bone Mineral Research). Also an active member of many NGO’s who are working in the health sector. Parathyroid Adenoma was treated first time in Asia and America by non-surgical technique (HIFU).
Designation: Additional Director
Department: Diabetology & Endocrinology Languages spoken: English, Hindi & Punjabi
Total Years’ of Experience: 23 yPrevious experience: Prior to joining Fortis Hospital Mohali, Dr. Singh worked as an Assistant Professor Endocrinology in P.G.I.M.E.R Chandigarh for 3 years. He was instrumental in establishing the Department of Endocrinology, S.V. Institute of Medical Sciences Tirupati Andhra Pradesh.Medical Education, Certifications and fellowships/Research Papers:
MBBS 1985
MD (Medicine) 1988
DM (Endocrinology) 1991
Global Advanced Therapeutics and Technologies in Diabetes Care program 2007
FICN (Fellow International College of Nutrition) Professional Memberships: He is a Member and Regular Participant of Annual Conferences of American Diabetic Association (ADA), American Endocrine Society (AES), American Association of Clinical Endocrinologist (AACE) and ASBMR (American Society for Bone Mineral Research), Member of EASD and ICE. Also an active member of many NGO’s who are working for the health sector.
linical Interests/ Specialised Treatments /Area of Expertise: Growth hormone therapy in burns, chronic fluoride toxicity in children and Metformin Osteoporosis link, HIFU treatment of parathyroid Adenoma (1st time in Asia)
Awards & Honors (If any): Dr Singh is a recipient of WHO International Diabetes Center award from Minneapolis 2007 and National Builders Award 2007. His biography has been included in the 2008 Marquis Who’s Who In World and Oxford International Biographical Centre, Cambridge, UK.
Research and Publications (If any): Total of 45 Publications as original articles and abstracts in international conference proceedings
Medical Breakthroughs/ Interesting Case Studies:
• Growth Hormone Therapy in Burns on Mortality (First time in Asia)
• Treated Parathyroid Adenoma by HIFU (First time in Asia and America)
• Metformin and osteoporosis link